Company intelligence / Profile preview
Chance Pharmaceuticals
Hangzhou, Zhejiang Province, Chinachancepharmaceuticals.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Chance Pharmaceuticals is a clinical-stage biotechnology company specializing in innovative dry powder inhalation therapies. Its lead asset, CXG87—an improved budesonide/formoterol DPI—is in Phase III trials. The company leverages proprietary spray-drying technology to develop efficient inhaled formulations targeting respiratory and other serious diseases. Recent funding will accelerate late-stage clinical development and expand the pipeline.
- Therapeutic areas
- PulmonologyCardiovascularRare DiseasesNeurology
- Modalities
- Dry powder inhalation (DPI) therapiesInhaled small moleculesInhaled biologics
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
Acorda Therapeutics (for INBRIJA® distribution/licensing in Greater China)Aerami Therapeutics Inc. (exclusive license for AER901/imatinib DPI for PAH)
Beyond the preview
Go deeper on Chance Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chance Pharmaceuticals.